Researchers at the Terasaki Institute for Biomedical Innovation have developed a novel nanoparticle-based therapy for obesity treatment, as reported in a recent study published in ACS Nano. The innovative approach targets inflammatory cells in adipose tissue, modulating the immune system and promoting fat tissue browning. The research addresses the growing global obesity epidemic and the limitations of current treatment options.